CA
FENC icon

Cliff Asness’s Fennec Pharmaceuticals FENC Stock Holding History

Cliff Asness’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$999K Buy
92,889
+68,743
+285% +$561K ﹤0.01% 3004
2026
Q1 		$148K Buy
24,146
+9,007
+59% +$69.5K ﹤0.01% 3648
2025
Q4 		$117K Buy
15,139
+127
+0.8% +$1.04K ﹤0.01% 3452
2025
Q3 		$141K Buy
15,012
+700
+5% +$6.06K ﹤0.01% 3324
2025
Q2 		$119K Buy
14,312
+3,415
+31% +$23.4K ﹤0.01% 3148
2025
Q1 		$66.4K Buy
+10,897
New +$70K ﹤0.01% 3065
2021
Q2 		– Sell
-12,977
Closed -$81K – 2251
2021
Q1 		$81K Sell
12,977
-3,614
-22% -$27.2K ﹤0.01% 2162
2020
Q4 		$124K Sell
16,591
-5,168
-24% -$39.4K ﹤0.01% 2137
2020
Q3 		$132K Buy
+21,759
New +$153K ﹤0.01% 2110
2018
Q4 		– Sell
-20,560
Closed -$169K – 2217
2018
Q3 		$169K Buy
20,560
+4,429
+27% +$41.1K ﹤0.01% 2218
2018
Q2 		$168K Buy
+16,131
New +$191K ﹤0.01% 2243

Other funds holding FENC

RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $1.59B AUM 855.46% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $187M AUM 12.91% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AIC
AWM Investment Company New York $1.15B AUM 201.65% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCA
Prospect Capital Advisors Sausalito, California $220M AUM 60.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Cliff Asness's FENC Position: Q2 2026 in Review

Cliff Asness increased its Fennec Pharmaceuticals (FENC) stake by 285% in Q2 2026, buying an estimated $561K and bringing the position to 92,889 shares worth $999K. The position accounts for ﹤0.01% of the portfolio, ranked #3004.

Cliff Asness first reported a position in FENC in Q2 2018 and has held it in 11 quarters since. 104 funds tracked by Wall St. Rank hold FENC as of Q2 2026.

  • Cliff Asness held 92,889 shares of Fennec Pharmaceuticals worth $999K as of Q2 2026.
  • Cliff Asness bought 68,743 Fennec Pharmaceuticals shares in Q2 2026, an estimated $561K.
  • Fennec Pharmaceuticals made up ﹤0.01% of Cliff Asness's portfolio in Q2 2026, its #3004 holding.
  • Cliff Asness first reported a position in Fennec Pharmaceuticals in Q2 2018 and has held it in 11 quarters since.
  • 104 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.